130 related articles for article (PubMed ID: 36994661)
1. Natural killer cells suppress human cutaneous squamous cell carcinoma cancer cell survival and tumor growth.
Adhikary G; Heipertz EL; Preradovic M; Chen X; Xu W; Newland JJ; Kaur N; Vemuri MC; Eckert RL
Mol Carcinog; 2023 Jun; 62(6):845-854. PubMed ID: 36994661
[TBL] [Abstract][Full Text] [Related]
2. YAP1/Piezo1 involve in the dynamic changes of lymphatic vessels in UVR-induced photoaging progress to squamous cell carcinoma.
Yang YL; Zhou C; Chen Q; Shen SZ; Li JD; Wang XL; Wang PR
J Transl Med; 2023 Nov; 21(1):820. PubMed ID: 37974224
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA PICSAR knockdown inhibits the progression of cutaneous squamous cell carcinoma by regulating miR-125b/YAP1 axis.
Lu X; Gan Q; Gan C; Zheng Y; Cai B; Li X; Li D; Yin G
Life Sci; 2021 Jun; 274():118303. PubMed ID: 32841663
[TBL] [Abstract][Full Text] [Related]
4. Sulforaphane inhibits CD44v6/YAP1/TEAD signaling to suppress the cancer phenotype.
Chen X; Adhikary G; Ma E; Newland JJ; Naselsky W; Xu W; Eckert RL
Mol Carcinog; 2023 Feb; 62(2):236-248. PubMed ID: 36285644
[TBL] [Abstract][Full Text] [Related]
5. VGLL4 inhibits YAP1/TEAD signaling to suppress the epidermal squamous cell carcinoma cancer phenotype.
Mickle M; Adhikary G; Shrestha S; Xu W; Eckert RL
Mol Carcinog; 2021 Jul; 60(7):497-507. PubMed ID: 34004031
[TBL] [Abstract][Full Text] [Related]
6. Dual inhibition of epidermal growth factor receptor and insulin-like growth factor receptor I: reduction of angiogenesis and tumor growth in cutaneous squamous cell carcinoma.
Galer CE; Corey CL; Wang Z; Younes MN; Gomez-Rivera F; Jasser SA; Ludwig DL; El-Naggar AK; Weber RS; Myers JN
Head Neck; 2011 Feb; 33(2):189-98. PubMed ID: 20848439
[TBL] [Abstract][Full Text] [Related]
7. USF1-induced upregulation of LINC01048 promotes cell proliferation and apoptosis in cutaneous squamous cell carcinoma by binding to TAF15 to transcriptionally activate YAP1.
Chen L; Chen Q; Kuang S; Zhao C; Yang L; Zhang Y; Zhu H; Yang R
Cell Death Dis; 2019 Apr; 10(4):296. PubMed ID: 30931936
[TBL] [Abstract][Full Text] [Related]
8. Development of CAR-NK Cells Targeting cSCC-Specific Antigens for Precision Immunotherapy.
Tayanloo-Beik A; Roudsari PP; Aghayan H; Arjmand R; Rezaei-Tavirani M; Larijani B; Rajaeinejad M; Mosaed R; Arjmand B
Methods Mol Biol; 2023 Dec; ():. PubMed ID: 38095836
[TBL] [Abstract][Full Text] [Related]
9. Specific knockdown of HOXB7 inhibits cutaneous squamous cell carcinoma cell migration and invasion while inducing apoptosis via the Wnt/β-catenin signaling pathway.
Gao D; Chen HQ
Am J Physiol Cell Physiol; 2018 Nov; 315(5):C675-C686. PubMed ID: 30067384
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast growth factor receptor promotes progression of cutaneous squamous cell carcinoma.
Khandelwal AR; Kent B; Hillary S; Alam MM; Ma X; Gu X; DiGiovanni J; Nathan CO
Mol Carcinog; 2019 Oct; 58(10):1715-1725. PubMed ID: 31254372
[TBL] [Abstract][Full Text] [Related]
11. Artesunate restrains the malignant progression of human cutaneous squamous cell carcinoma cells via the suppression of the PI3K/AKT pathway.
Huang X; Zhang S; Wang W
Tissue Cell; 2022 Jun; 76():101789. PubMed ID: 35338984
[TBL] [Abstract][Full Text] [Related]
12. EphB2 Promotes Progression of Cutaneous Squamous Cell Carcinoma.
Farshchian M; Nissinen L; Siljamäki E; Riihilä P; Toriseva M; Kivisaari A; Ala-Aho R; Kallajoki M; Veräjänkorva E; Honkanen HK; Heljasvaara R; Pihlajaniemi T; Grénman R; Peltonen J; Peltonen S; Kähäri VM
J Invest Dermatol; 2015 Jul; 135(7):1882-1892. PubMed ID: 25789706
[TBL] [Abstract][Full Text] [Related]
13. The Synthetic Flavonoid Derivative GL-V9 Induces Apoptosis and Autophagy in Cutaneous Squamous Cell Carcinoma via Suppressing AKT-Regulated HK2 and mTOR Signals.
Zhu Y; Liu M; Yao J; Guo Q; Wei L
Molecules; 2020 Oct; 25(21):. PubMed ID: 33143000
[TBL] [Abstract][Full Text] [Related]
14. Cetuximab therapy in head and neck cancer: immune modulation with interleukin-12 and other natural killer cell-activating cytokines.
Luedke E; Jaime-Ramirez AC; Bhave N; Roda J; Choudhary MM; Kumar B; Teknos TN; Carson WE
Surgery; 2012 Sep; 152(3):431-40. PubMed ID: 22770960
[TBL] [Abstract][Full Text] [Related]
15. GRIM-19 represses the proliferation and invasion of cutaneous squamous cell carcinoma cells associated with downregulation of STAT3 signaling.
Wu N; Hui H; Cui L; Yang F
Biomed Pharmacother; 2017 Nov; 95():1169-1176. PubMed ID: 28926927
[TBL] [Abstract][Full Text] [Related]
16. Circular RNA circ-LARP1B contributes to cutaneous squamous cell carcinoma progression by targeting microRNA-515-5p/TPX2 microtubule nucleation factor axis.
Wang L; Hou S; Li J; Tian T; Hu R; Yu N
Bioengineered; 2022 Jan; 13(1):1209-1223. PubMed ID: 34982022
[TBL] [Abstract][Full Text] [Related]
17. Tumor cell-specific AIM2 regulates growth and invasion of cutaneous squamous cell carcinoma.
Farshchian M; Nissinen L; Siljamäki E; Riihilä P; Piipponen M; Kivisaari A; Kallajoki M; Grénman R; Peltonen J; Peltonen S; Quint KD; Bavinck JNB; Kähäri VM
Oncotarget; 2017 Jul; 8(28):45825-45836. PubMed ID: 28526809
[TBL] [Abstract][Full Text] [Related]
18. H-Ras activation and fibroblast-induced TGF-β signaling promote laminin-332 accumulation and invasion in cutaneous squamous cell carcinoma.
Siljamäki E; Rappu P; Riihilä P; Nissinen L; Kähäri VM; Heino J
Matrix Biol; 2020 May; 87():26-47. PubMed ID: 31655292
[TBL] [Abstract][Full Text] [Related]
19. Real-Time Tracking of
Uong TNT; Lee KH; Ahn SJ; Kim KW; Min JJ; Hyun H; Yoon MS
Front Immunol; 2018; 9():825. PubMed ID: 29770131
[TBL] [Abstract][Full Text] [Related]
20. GDC-0084 inhibits cutaneous squamous cell carcinoma cell growth.
Ding LT; Zhao P; Yang ML; Lv GZ; Zhao TL
Biochem Biophys Res Commun; 2018 Sep; 503(3):1941-1948. PubMed ID: 30072096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
